Accelerant Holdings
NYSE:ARXInsurance - Brokers
-$0.33 today
- Market cap
- $4.33B
- Beta
- -0.77
- P/E (TTM)
- -2.1
- EPS (TTM)
- -$6.15
Volume 0.82M
Average 1.42M
ARX Sales of Investments
Cash received from selling or redeeming investments.
Accelerant HoldingsNYSE: ARX
Sales of Investments · Q3 FY2026 · quarter ended Sep 2026
Sales of investments turns negative
Q3 FY2026 sales of investments was -$900K, compared with $0 a year earlier. Trailing-twelve-month sales of investments was $184M. Over 3 fiscal years it compounded at +36.3% a year.
Context
- Sales of investments amounted to 44.1% of revenue in FY2025, up 7.6 pp from a year earlier.
- Sales of investments increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly sales of investments holds near -$900K or moves back toward the trailing-twelve-month quarterly average of $46M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 388M USD
- Year-over-year change
- +78.0%
- 4-year CAGR
- +91.4%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 388M | +78.0% |
| FY2024 | 2024-12-31 | 218M | +54.8% |
| FY2023 | 2023-12-31 | 140.8M | -8.2% |
| FY2022 | 2022-12-31 | 153.3M | +430.4% |
| FY2021 | 2021-12-31 | 28.9M | — |
Sales of Investments vs competitors
How ARX compares with its peers on the latest reported figures
- ARX's LTM Sep 2026 sales of investments of $184M is the 7th largest of the 10 companies compared; the peer median is $1.01B.
- Its year-over-year change of +4.7% is the 7th highest of 9, against a peer median of +68.7%.
- Sales of investments amounts to 19.0% of revenue for ARX, versus a peer median of 33.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $5.54B | +70.3% | -13.6% | 185.4% | |
| LTM Jun 2026 | $3.82B | +39110.3% | — | 17.7% | |
| LTM Jun 2026 | $2.67B | +345.5% | +31.0% | 468.0% | |
| LTM Jun 2026 | $1.14B | +31.7% | -4.8% | 161.0% | |
| LTM Jun 2026 | $1.01B | +572.8% | +32.4% | 166.7% | |
| LTM Jun 2026 | $436.27M | +67.2% | +30.5% | 33.6% | |
ARXAccelerant Holdings | LTM Sep 2026 | $184M | +4.7% | +36.3% | 19.0% |
| LTM Jun 2026 | $47.05M | -108.6% | +50.8% | 4.9% | |
| LTM Sep 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ARX) | $1.01B | +68.7% | +30.8% | 33.6% | |
Competitors are the stored peer set for ARX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (24.4M) | (96.4M) | (64.1M) | 22.4M | (1.35B) |
| Depreciation & Amortization | 1.6M | 5.8M | 14.5M | 26.6M | 35.2M |
| Deferred Income Tax | (1.7M) | (5.8M) | 300K | (40.9M) | (32M) |
| Stock-Based Compensation | 0 | 0 | 4.8M | 8.4M | 43.1M |
| Change in Working Capital | 127.7M | 157.9M | 356.5M | 801.1M | 397.8M |
| Accounts Receivables | (181.9M) | (370.1M) | (636.7M) | (782.5M) | (1.07B) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 106.9M | 111.7M | 320.2M | 708.9M | 87.1M |
| Other Working Capital | 202.7M | 416.3M | 673M | 874.7M | 1.38B |
| Other Non-Cash Items | 9.5M | 4.2M | (22.1M) | (32.1M) | 1.35B |
| Operating Cash Flow | 112.7M | 65.7M | 289.9M | 785.5M | 445.1M |
| Capital Expenditures | (14.7M) | (26.7M) | (32.6M) | (34.4M) | (41.4M) |
| Acquisitions (Net) | (21.2M) | (11.2M) | 2.2M | (4.8M) | (10.4M) |
| Purchases of Investments | (125.4M) | (263.5M) | (122M) | (557.6M) | (509.3M) |
| Sales of Investments | 28.9M | 153.3M | 140.8M | 218M | 388M |
| Other Investing Activities | (100K) | 600K | (100K) | (1.3M) | (500K) |
| Investing Cash Flow | (132.5M) | (147.5M) | (11.7M) | (380.1M) | (173.6M) |
| Debt Repayment | 49.5M | 51.3M | 18M | (700K) | (800K) |
| Common Stock Issued | 30.9M | 0 | 0 | 0 | 392M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (175.3M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (1.4M) | (8.4M) | (3.5M) | 165.2M |
| Financing Cash Flow | 233.7M | 254.7M | 10.3M | 110.3M | 205.8M |
| Effect of Forex Changes | 2.2M | (14.6M) | 3.3M | (18.3M) | 49M |
| Net Change in Cash | 216.1M | 158.3M | 291.8M | 497.4M | 526.3M |
| Free Cash Flow | 98M | 39M | 257.3M | 751.1M | 403.7M |
Accelerant Holdings
NYSE:ARX
Intrinsic Alpha fair value
Locked
Current Price
$19.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.